NEPHROQUIN
ActiveSummary
NEPHROQUIN has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €327,980 and a net result of €108,172. Equity is growing by ~16.4% per year across the filed fiscal years. Its solvency ranks better than 59% of 16810 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability98▲+6
Solvency97▲+6
Growth52=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30,000 at 30 days acceptable
Liquidity ample (current ratio 3.17 against 3.01 in 2024; short-term debt: 28% and cash: 74.6% of total assets), and 28% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
72%
Return on assets
23.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
30 d early
2024
26 d early
2023
31 d early
2022
31 d late
2021
18 d early
2020
32 d early
2019
18 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 18 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 5 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
In the rankings
#8 company by equity in Spa, Health and social work sector
Turnover
€194,427
EBIT margin
38.7%
Net result
€108,172▲ 35.8%
2024 · €79,664
Working capital
€276,495▲ 16.6%
2024 · €237,187
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Turnover€194,427
Operating result€39,241▼ 40.6%€75,315▲ 91.9%€83,679▲ 11.1%€105,144▲ 25.7%€148,833▲ 41.6%
Net result€30,438within the sector's middle half▼ 41.9%€59,465within the sector's middle half▲ 95.4%€59,734within the sector's middle half▲ 0.5%€79,664within the sector's middle half▲ 33.4%€108,172within the sector's middle half▲ 35.8%
EBIT margin38.7%
Equity€174,745within the sector's middle half▼ 4.7%€200,410within the sector's middle half▲ 14.7%€260,144within the sector's middle half▲ 29.8%€279,808within the sector's middle half▲ 7.6%€327,980within the sector's middle half▲ 17.2%
Total assets€219,572within the sector's middle half▲ 4.9%€241,920within the sector's middle half▲ 10.2%€367,290within the sector's middle half▲ 51.8%€421,864within the sector's middle half▲ 14.9%€455,578within the sector's middle half▲ 8.0%
Debt€44,827▲ 72.6%€41,510▼ 7.4%€107,146▲ 158%€142,055▲ 32.6%€127,598▼ 10.2%
Working capital€165,627within the sector's middle half▼ 4.2%€195,029within the sector's middle half▲ 17.8%€228,792within the sector's middle half▲ 17.3%€237,187within the sector's middle half▲ 3.7%€276,495above the sector's middle half▲ 16.6%
Solvency79.6%within the sector's middle half▼ 8.0pp82.8%within the sector's middle half▲ 3.3pp70.8%within the sector's middle half▼ 12.0pp66.3%within the sector's middle half▼ 4.5pp72.0%within the sector's middle half▲ 5.7pp
Current ratio4.76within the sector's middle half▼ 2.945.77within the sector's middle half▲ 1.015.18within the sector's middle half▼ 0.593.01within the sector's middle half▼ 2.163.17within the sector's middle half▲ 0.15
Return on assets (ROA)13.9%within the sector's middle half▼ 11.2pp24.6%within the sector's middle half▲ 10.7pp16.3%within the sector's middle half▼ 8.3pp18.9%within the sector's middle half▲ 2.6pp23.7%within the sector's middle half▲ 4.9pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 42% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €455,578
Fixed assets
€51,485 ▼ 23.1%
Current assets
€404,093 ▲ 13.8%
Equity and liabilities €455,578
Equity
€327,980 ▲ 17.2%
Debt
€127,598 ▼ 10.2%
Debt's share of the balance-sheet total falls from 33.7% to 28.0%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€166,502▲
2024 · €122,544
Cash flow
€125,842▲
2024 · €97,064
Debt to equity
0.39▼
2024 · 0.51
ROE
33.0%▲
2024 · 28.5%
Interest coverage
85.55▲
2024 · 39.72
Debt ≤ 1 year
€127,598▲
2024 · €117,754
Income taxes
€38,932▲
2024 · €22,450
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,781 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 97% are still going.
- Small
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.6%
went bankrupt
2.7%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,781 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | - | €194,427 | - | - | - | - |
| Goods, raw materials, services and sundry goods60/61 | - | €116,076 | - | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €3,879 | €3,879 | €6,571 | €17,400 | €17,669 | ▲ 1.5% |
| Other operating charges640/8 | €702 | €556 | €1,219 | €2,515 | €1,236 | ▼ 50.8% |
| Gross operating margin9900 | €43,822 | €79,750 | €91,469 | €125,059 | €167,738 | ▲ 34.1% |
| Operating profit (loss)9901 | €39,241 | €75,315 | €83,679 | €105,144 | €148,833 | ▲ 41.6% |
| Financial income75/76B | €0 | €90 | €39 | €56 | €217 | ▲ 291% |
| Recurring financial income75 | €0 | €90 | €39 | €56 | €217 | ▲ 291% |
| Financial charges65/66B | €93 | €226 | €911 | €3,085 | €1,946 | ▼ 36.9% |
| Recurring financial charges65 | €93 | €226 | €911 | €3,085 | €1,946 | ▼ 36.9% |
| Profit (loss) for the period before taxes9903 | €39,149 | €75,179 | €82,807 | €102,114 | €147,104 | ▲ 44.1% |
| Income taxes67/77 | €8,711 | €15,714 | €23,072 | €22,450 | €38,932 | ▲ 73.4% |
| Profit (loss) for the period9904 | €30,438 | €59,465 | €59,734 | €79,664 | €108,172 | ▲ 35.8% |
| Profit (loss) for the period to be appropriated9905 | €30,438 | €59,465 | €59,734 | €79,664 | €108,172 | ▲ 35.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €219,572 | €241,920 | €367,290 | €421,864 | €455,578 | ▲ 8.0% |
| Fixed assets21/28 | €9,865 | €5,986 | €83,724 | €66,923 | €51,485 | ▼ 23.1% |
| Tangible fixed assets22/27 | €7,395 | €3,516 | €81,254 | €64,453 | €49,015 | ▼ 24.0% |
| Furniture and vehicles24 | €7,395 | €3,516 | €81,254 | €64,453 | €49,015 | ▼ 24.0% |
| Financial fixed assets28 | €2,470 | €2,470 | €2,470 | €2,470 | €2,470 | = |
| Current assets29/58 | €209,707 | €235,934 | €283,566 | €354,941 | €404,093 | ▲ 13.8% |
| Amounts receivable within one year40/41 | €39,171 | €38,534 | €59,713 | €20,832 | €41,308 | ▲ 98.3% |
| Trade receivables40 | €12,760 | €14,958 | €5,217 | - | - | - |
| Other amounts receivable41 | €26,411 | €23,576 | €54,496 | €20,832 | €41,308 | ▲ 98.3% |
| Cash at bank and in hand54/58 | €167,287 | €194,307 | €208,101 | €319,071 | €339,814 | ▲ 6.5% |
| Deferred charges and accrued income490/1 | €3,249 | €3,093 | €15,753 | €15,038 | €22,970 | ▲ 52.7% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €219,572 | €241,920 | €367,290 | €421,864 | €455,578 | ▲ 8.0% |
| Equity10/15 | €174,745 | €200,410 | €260,144 | €279,808 | €327,980 | ▲ 17.2% |
| Contributions10/11 | €13,400 | €19,600 | €19,600 | €19,600 | €19,600 | = |
| Reserves13 | €160,860 | €180,810 | €240,544 | €260,208 | €308,380 | ▲ 18.5% |
| Distributable reserves133 | €160,860 | €180,810 | €240,544 | €260,208 | €308,380 | ▲ 18.5% |
| Profit (loss) carried forward14 | €485 | €0 | - | - | - | - |
| Amounts payable17/49 | €44,827 | €41,510 | €107,146 | €142,055 | €127,598 | ▼ 10.2% |
| Amounts payable after more than one year17 | - | - | €52,371 | €24,301 | - | - |
| Financial debts170/4 | - | - | €52,371 | €24,301 | - | - |
| Amounts payable within one year42/48 | €44,080 | €40,905 | €54,775 | €117,754 | €127,598 | ▲ 8.4% |
| Financial debts43 | - | €0 | €26,926 | €28,070 | €24,301 | ▼ 13.4% |
| Credit institutions430/8 | - | €0 | €26,926 | €28,070 | €24,301 | ▼ 13.4% |
| Trade debts44 | €2,580 | €905 | €1,313 | €2,684 | €896 | ▼ 66.6% |
| Suppliers440/4 | €2,580 | €905 | €1,313 | €2,684 | €896 | ▼ 66.6% |
| Taxes, remuneration and social security45 | - | €0 | €26,536 | €27,000 | €42,400 | ▲ 57.0% |
| Taxes450/3 | - | €0 | €25,036 | €25,500 | €37,900 | ▲ 48.6% |
| Remuneration and social security454/9 | - | - | €1,500 | €1,500 | €4,500 | ▲ 200% |
| Other amounts payable47/48 | €41,500 | €40,000 | - | €60,000 | €60,000 | = |
| Accrued charges and deferred income492/3 | €747 | €604 | - | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €30,438 | €59,465 | €59,734 | €79,664 | €108,172 | ▲ 35.8% |
| + Depreciation and write-downs630 | €3,879 | €3,879 | €6,571 | €17,400 | €17,669 | ▲ 1.5% |
| Operating cash flow (approximation) | €34,318 | €63,344 | €66,306 | €97,064 | €125,842 | ▲ 29.6% |
| Investment in fixed assets (approximation) | - | €0 | -€84,310 | -€599 | -€2,232 | ▼ 273% |
| Change in cash | - | €27,020 | €13,794 | €110,970 | €20,743 | ▼ 81.3% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
01-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
05-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-12
Financial
Equity above €200,000Eq €200,410 ▲14.7%
4 profitable years in a row build equity to €200,410.
13-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Weakest financial yearnet €30,438 ▼41.9%
Net result drops to €30,438, the lowest in the series; recovery starts the following year.
29-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Liquidity doublescurrent ratio 7.70
Current ratio from 3.53 to 7.70; short-term debt falls from €46,675 to €25,812.
31-12
Financial
Equity above €150,000Eq €183,307 ▲40.1%
2 profitable years in a row build equity to €183,307.
13-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Spa · 2 establishment units since 2019
Ground area
913 m²
Building footprint
348 m²
Volume, LiDAR
6,797 m³
2 parcels, Wallonia · tallest building 24.2 m, ±7 floors. Linked by address, not a title deed.
2 establishment units
NEPHROQUIN
since 20192.286.860.023
Avenue Reine Astrid 54, 4900 Spa
since 20212.325.206.596
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 63072G0419/00K000 | Wallonia | 839 m² | 1 · 276 m² | 24.2 m · 7 fl. |
| 63072G0687/00X000indicative | Wallonia | 74 m² | 1 · 72 m² | 13.3 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR MARJORIE DUFAUX
BE 0755.965.342
Profondeville · Eq €328,023
DR.LAMBERT VERONIQUE
BE 0810.499.237
Torhout · Eq €328,254
CENTRE DE MEDECINE MEDIDEL
BE 0444.511.705
Walcourt · Eq €328,258
DR. INGE SCHOEFS
BE 0842.114.903
Tongeren-Borgloon · Eq €328,406
CABINET MEDICAL JEAN-LOUIS MARCHAND
BE 0825.321.926
Brunehaut · Eq €328,482
Of 9,130 companies in sector 86210 we hold annual accounts for 6,337. 5,183 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded26-02-2019
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0721598242
Registered
21-03-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.